Issue 12/2020
Content (33 Articles)
Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors
Stefani Parmentier, Michael Kramer, Swetlana Weller, Ulrich Schuler, Rainer Ordemann, Gabi Rall, Markus Schaich, Martin Bornhäuser, Gerhard Ehninger, Frank Kroschinsky
Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel
Idit Pazgal, Vered Yahalom, Bruria Shalev, Pia Raanani, Pinhas Stark
Influence of rs1042713 and rs1042714 polymorphisms of β2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India
Shalini Sinha, Bimal Prasad Jit, A. Raj Kumar Patro, Aisurya Ray, Snehadhini Dehury, Sarmila Sahoo, Rajendra Kumar Behera, Pradeep Kumar Mohanty, Pinaki Panigrahi, Padmalaya Das
Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China
Yuanjun Wu, Qianyu Yao, Ming Zhong, Jianying Wu, Longxu Xie, Linnan Su, Fubing Yu
Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China
Jing Ruan, Wei Zuo, Miao Chen, Chen Yang, Bing Han
Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting
Cihan Ay, Leonard Perschy, Judit Rejtö, Alexandra Kaider, Ingrid Pabinger
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients
Emilia Scalzulli, Gioia Colafigli, Roberto Latagliata, Sara Pepe, Daniela Diverio, Francesca Stocchi, Alessio Di Prima, Fabio Efficace, Maurizio Martelli, Robin Foà, Massimo Breccia
Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis
Marko Lucijanic, Davor Galusic, Ivan Krecak, Martina Sedinic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic, Rajko Kusec
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia
Hitoshi Minamiguchi, Hiroyuki Fujita, Yoshiko Atsuta, Norio Asou, Toru Sakura, Yasunori Ueda, Masashi Sawa, Nobuaki Dobashi, Yasuhiro Taniguchi, Rikio Suzuki, Yoshihito Uchino, Akihiro Tomita, Shigehisa Tamaki, Maki Hagihara, Katsumichi Fujimaki, Masamitsu Yanada, Yoshinobu Maeda, Masako Iwanaga, Noriko Usui, Yukio Kobayashi, Shigeki Ohtake, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Akihiro Takeshita
Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study
Chong Wei, Xinxin Cao, Wei Zhang, Yan Zhang, Wei Wang, Lu Zhang, Chen Yang, Jun Feng, Huacong Cai, Miao Chen, Yueying Mao, Daobin Zhou
A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment
Zegeng Chen, Xiaojie Fang, He Huang, Zhao Wang, Huangming Hong, Meiting Chen, Quanguang Ren, Yuyi Yao, Limei Zhang, Ying Tian, Suxia Lin, Tongyu Lin
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis
M. Pouyiourou, A. Meyer, A. Stroux, A. Viardot, P. La Rosée, G. Maschmeyer, D. Kämpfe, C. Kahl, V. Vucinic, A. Monecke, C. Hirt, T. Weber, J. Meissner, M. Witzens-Harig, S. Böttcher, H. Schmalenberg, R. Marks, G. Prange-Krex, F. Kroschinsky, E. Hauf, U. Keller, K. Koch, W. Klapper, M. Herold, Christian W. Scholz
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)
Sora Kang, Hyungwoo Cho, Byeong Seok Sohn, Sung Yong Oh, Won-Sik Lee, Sang Min Lee, Deok-Hwan Yang, Jooryung Huh, Dok Hyun Yoon, Cheolwon Suh
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma
Andrew Davies, Peter Trask, Judit Demeter, Axel Florschütz, Mathias Hänel, Tomohiro Kinoshita, Ruth Pettengell, Hang Quach, Stephen Robinson, Shalal Sadullah, Juan-Manuel Sancho, Miklos Udvardy, Mathias Witzens-Harig, Andrea Knapp, Wenxin Liu
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma
Haizhu Chen, Yan Qin, Jianliang Yang, Peng Liu, Changgong Zhang, Xiaohui He, Shengyu Zhou, Sheng Yang, Lin Gui, Liqiang Zhou, Yan Sun, Yuankai Shi
Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma
Toshihiro Matsukawa, Keito Suto, Minoru Kanaya, Koh Izumiyama, Koichiro Minauchi, Shota Yoshida, Hisashi Oda, Takuto Miyagishima, Akio Mori, Shuichi Ota, Daigo Hashimoto, Takanori Teshima
Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma
Charles Mesguich, Cyrille Hulin, Valerie Latrabe, Axelle Lascaux, Laurence Bordenave, Elif Hindié, Gerald Marit
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen
Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, Michał Szczyrek, Aleksandra Nowaczyńska, Iwona Homa-Mlak, Szymon Zmorzyński, Kinga Kuśmierczuk, Jacek Sompor, Agata Filip, Teresa Małecka-Massalska, Marek Hus
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma
Takashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-ichi Ochi, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Chihiro Yamamoto, Shin-ichiro Fujiwara, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients
Salvatore Palmieri, S. Rocco, O. Vitagliano, L. Catalano, C. Cerchione, I. D. Vincelli, A. Scopelliti, M. Gentile, G. Farina, M. Barone, A. Gagliardi, D. Esposito, M. Arcamone, V. Amico, R. Fontana, A. Sementa, A. Sica, G. Svanera, F. Pane, F. Ferrara
Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status
Yue Lu, Yan-Li Zhao, Jian-Ping Zhang, Min Xiong, Xing-Yu Cao, De-Yan Liu, Rui-Juan Sun, Zhi-Jie Wei, Jia-Rui Zhou, Dao-Pei Lu
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT
Satoshi Yamasaki, Jinichi Mori, Junya Kanda, Nobuhiko Imahashi, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Yuta Katayama, Tetsuya Eto, Yukiyasu Ozawa, Satoru Takada, Makoto Onizuka, Masayuki Hino, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada
Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia
Liat Shargian-Alon, Ofir Wolach, Uri Rozovski, Dafna Yahav, Michal Sela-Navon, Mazal Rubinstein, Nino Oniashvilli, Oren Pasvolsky, Pia Raanani, Moshe Yeshurun
Borrelia burgdorferi mimicking central nervous system relapse in diffuse large B cell lymphoma
Marcel Nijland, Martijn Bakker, Kees Meijer, Wouter Plattel
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus–positive plasma cell myeloma
Thomas S. Y. Chan, Alvin H. W. Ip, Rex Au-Yeung, Annie W. K. Pang, Yok-Lam Kwong
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, Elena Vera, Marta Hidalgo, Nieves Lopez, Clara Cuellar, Irene Zamanillo, Rodrigo Íñiguez, Estela Paz-Artal, José M. Aguado, J. Martinez-Lopez
Bone marrow coexistence of chronic lymphocytic leukemia and Langerhans cell sarcoma
Magda Zanelli, Stefano Ricci, Maurizio Zizzo, Francesca Sanguedolce, Giovanni Martino, Giulio Fraternali Orcioni, Stefano Ascani
Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)
Elena Guillen, Enrique Montagud-Marrahi, Diana M. Rodriguez, Evelyn Hermida, Raul A. Padilla, Miquel Blasco, M. Teresa Cibeira, Rodrigo Martino, Carlos Fernandez de Larrea, J. M. Campistol, Luis F. Quintana
Early-stage mantle cell lymphoma—a rare entity with special characteristics and needs for treatment
Lena Specht
Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations
Shruthi Suryaprakash, Amy George, Scott Langenburg, Süreyya Savaşan
Rare synchronous co-existence of acute myeloid leukemia and hairy cell leukemia in a same patient
Xiaofeng Shi, Qian Jiang, Haiyan You, Yichen Liu, Min Chen, Tiantian Li, Jie Peng, Rong Huang, Jingan Liu, Yilin Zhu, Xiaodong Xi
Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm
Matthew Schwede, Irena T. Tan, Danielle F. Atibalentja, Meghan M. Dickman, Kerri E. Rieger, Gabriel N. Mannis